AVM Biotechnology LLC   Report issue

For profit Phase 2
Founded: Seattle WA United States (2008)

Organization Overview

First Clinical Trial
2020
NCT04329728
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

AVM Biotechnology LLC